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uct, formed during storage of cholesterol or artifactually 
produced during work-up of tissue samples ( 1, 2 ). Enzy-
matic formation of 25-hydroxycholesterol by rat liver mito-
chondria was described in 1974 ( 3 ), and it was later shown 
that 25-hydroxycholesterol is formed as a by-product dur-
ing cholesterol oxidation by the mitochondrial enzyme 
sterol 27-hydroxylase in liver in pig ( 4 ) and mouse ( 5 ). In 
addition to the formation of 25-hydroxycholesterol by 
sterol 27-hydroxylase (CYP27A1), a specifi c human mi-
crosomal cholesterol 25-hydroxylase has been cloned and 
characterized ( 6 ). This enzyme does not belong to the cy-
tochrome P450 family but is related to the eukaryotic 
stearoyl-CoA desaturases ( 6 ). Low levels (3-5 ng/ml) of 25-
hydroxycholesterol are present in human plasma ( 7 ), but 
the relative contribution of CYP27A1 and cholesterol 25-
hydroxylase to its formation is not known. 
 25-Hydroxycholesterol is a potent regulatory oxysterol 
and may participate in several aspects of lipid metabolism 
( 8 ). A family of oxysterol binding proteins with high affi nity 
for 25-hydroxycholesterol has been identifi ed ( 9 ). Overex-
pression of oxysterol binding proteins in Chinese hamster 
ovary cells resulted in signifi cant changes in genes involved 
in lipid metabolism ( 10 ). Side chain oxidized oxysterols, 
such as 25-hydroxycholesterol, have been implicated in the 
regulation of cholesterol homeostasis for a long time but 
only recently was the mechanism clarifi ed. These oxysterols 
bind to proteins called Insigs, thereby blocking the sterol 
regulatory element binding protein signaling that regulates 
cholesterol biosynthesis ( 11 ). Furthermore, 25-hydroxy-
cholesterol has been shown to activate the nuclear receptor 
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sion profi les were compared with that of medium-treated control 
cells incubated for the same time. Cells from four individual mice 
of each genotype were used, and each mouse served as its own 
medium-treated control. In the time-course experiment, cells 
from two mice were treated with 10 ng/ml LPS or live  E. coli (one 
bacterium per macrophage) for increasing times, and their gene 
expression profi les were compared with that of the preceding 
time point in a loop design. Total RNA for microarray analysis was 
isolated with TRIzol reagent (Invitrogen) and RNeasy columns 
(Qiagen). RNA integrity was assessed using the 2100 Bioanalyzer 
(Agilent Technologies). The Operon Mus musculus ver. 1.1 probe 
set (Qiagen) consisting of >13,000 oligonucleotide probes (70-
mers) was printed in the Massachusetts General Hospital (Cam-
bridge, MA) microarray core facility using an Omnigrid 100 
(GeneMachines) on CodeLink-activated slides (Amersham). RNA 
was reverse transcribed and differentially labeled with Cy3 and 
Cy5 dyes (Amersham) using the Atlas PowerScript fl uorescent la-
beling kit (BD Biosciences). Labeled samples were hybridized 
overnight using an automated hybridization station (Genomic So-
lutions). Fluorescent images from the arrays were acquired using 
a GenePix 4000B microarray scanner and its accompanying soft-
ware (Axon Instruments). Data were normalized using the Bio-
Array Software Environment (http://base.thep.lu.se/). Higher-level 
data and statistical analysis was performed using the GeneSpring 
(Silicon Genetics) software. A detailed analysis of the entire mi-
croarray data set has been published elsewhere ( 18 ). 
 Quantitative real-time PCR 
 Bone marrow-derived macrophages were treated with PBS 
(vehicle) or 10 ng/ml LPS for 2 h. Total RNA was isolated us-
ing Trizol reagent (Invitrogen) and the E.Z.N.A. Total RNA 
kit (Omega Bio-Tek). RNA integrity and purity were analyzed 
with an Experion automated electrophoresis system (Bio-Rad) 
and a ND-1000 spectrophotometer (NanoDrop Technolo-
gies). Purifi ed total RNA was reverse transcribed with MMLV 
reverse transcriptase (Invitrogen), and quantitative real-time 
PCR was performed using SYBR Green PCR Master Mix and a 
7900HT Fast real-time PCR system (Applied Biosystems). Rela-
tive mRNA expression was calculated from standard curves, 
constructed by serial dilution of gel-purifi ed PCR products, 
and normalized to 18S rRNA expression. Primer pairs used 
were as follows: cholesterol 25-hydroxylase  ( Ch25h ) forward 
primer 5 ′ -TGCTACA ACGGTTCGGAGC-3 ′ and reverse primer 
5 ′ -AGAAG CCC ACGTAAGTGATGAT-3 ′ ,  Cyp27a1 forward 
primer 5 ′ - CCAGGCACAGGAGAGTACG-3 ′ and reverse primer 
5 ′ -GGGCAAGTGCAGCACATAG-3 ′ , and  Cyp7b1 forward primer 
5 ′ - AGCTGCTTACTGATGACGACC-3 ′ and reverse primer 5 ′ -AG T-
GAGCCACAGAATGCAAAT-3 ′ . 
 Oxysterol measurements 
 Bone marrow-derived macrophages were treated with PBS (ve-
hicle) or 10 ng/ml LPS for 6 or 24 h. Supernatant was collected, 
and dead cells and cell debris were removed by centrifugation. 
Adherent macrophages were washed twice with PBS before har-
vesting by scraping in 200 µl PBS. Supernatants and scraped cells 
were stored at   80°C until analyzed. Total protein concentration 
was measured with the BCA protein assay kit (Pierce). For 25-
hydroxycholesterol measurements, cells or cell culture medium 
were extracted according to Folch, Lees, and Sloane Stanley ( 19 ) 
and subsequently analyzed by isotope dilution GC-MS using 
deuterium-labeled internal standard as described earlier ( 7 ). 
 ELISA 
 RAW264.7 cells were treated with either increasing concentra-
tions of 25-hydroxycholesterol or fi xed concentrations of 25 or 
liver X receptor   (LXR  ) ( 12, 13 ), involved in the regula-
tion of lipid metabolism. It has been questioned whether 
oxysterols are natural ligands for LXR ( 14 ), but some 
support for their role as ligands has been obtained from 
experiments in triple knockout mice defi cient in the bio-
synthetic enzymes for 24-, 25-, and 27-hydroxycholesterol. 
While cholesterol feeding induced several LXR-responsive 
genes in wild-type mice, an impaired response was seen in 
the triple knockout mice ( 15 ). Recently, it was found that 
25-hydroxycholesterol binds to the Niemann-Pick, Type C1 
protein, a protein involved in cholesterol transport from lyso-
somes to the endoplasmic reticulum ( 16 ). Altogether, these 
studies suggest an important role for 25-hydroxycholesterol 
in the regulation of lipid metabolism. 
 Lipopolysaccharide (LPS; endotoxin) is an integral com-
ponent of the cell wall of Gram-negative bacteria, such as 
 Escherichia coli . LPS interaction with the Toll-like receptor 4 
(TLR4), MD-2, and CD14 receptor complex induces a host 
response to invading pathogens. There are two main sig-
naling pathways activated by TLR4, depending on the 
recruitment of separate sets of adaptor proteins: the Myeloid 
differentiation protein 88 (MyD88)-dependent pathway, 
involving Mal/TIRAP and MyD88, and the MyD88-
independent pathway, involving the TRIF and TRAM adap-
tors ( 17 ). The MyD88-dependent pathway leads to activation 
of the transcription factor NF-  B, whereas TRIF activates 
the transcription factor IRF3. Together, these pathways re-
sult in the induction of pro-infl ammatory genes with   B-
binding motifs or the interferon-sensitive response element 
in their promoter regions. 
 During screening of genes upregulated by LPS treat-
ment of bone marrow-derived mouse macrophages, it was 
unexpectedly found that cholesterol 25-hydroxylase was 
strongly upregulated. In this investigation, we have stud-
ied the LPS regulation of cholesterol 25-hydroxylase in 
mouse macrophages. We have also observed increased lev-
els of plasma 25-hydroxycholesterol in healthy human vol-
unteers exposed to endotoxin challenge. 
 EXPERIMENTAL PROCEDURES 
 Cell culture 
 The local Animal Care and Use Committee approved the ex-
perimental protocol used in the study, and all mice were bred 
in-house. Mice were anesthetized with isofl urane and euthanized 
by cervical dislocation. Bone marrow was isolated from 6 to 8 
week old C57BL/6 and MyD88-defi cient mice. Macrophages were 
derived from these marrows by culture in DMEM media supple-
mented with 10% FBS and 10 ng/ml recombinant granulocyte-
macrophage colony-stimulating factor (GM-CSF) for 6 days. Bone 
marrow-derived macrophages were treated with either  E. coli 0111 
LPS (Sigma-Aldrich), 25-hydroxylcholesterol (Sigma-Aldrich), or 
control medium at the concentrations and times specifi ed below. 
The mouse macrophage-like cell line RAW264.7 was cultured in 
DMEM media supplemented with 10% FBS. 
 Microarray expression analysis 
 For microarray analysis of the mRNA expression profi le in 
bone marrow-derived macrophages, cells were treated at day 8 ex 
vivo for 2 h with 10 ng/ml  E. coli 0111 LPS, and their gene expres-
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( Fig. 1B ). Furthermore, the increased  Ch25h expression 
was found to be independent of MyD88 signaling but de-
pendent on TLR4 signaling, as the LPS-induced  Ch25h 
expression was not impaired in mice with a targeted 
disruption of the MyD88 gene but severely impaired in 
TLR4-defi cient mice ( Fig. 1C ). These data imply that LPS-
induced  Ch25h expression is controlled by the MyD88-
independent TLR4/TRIF dependent pathway. 
 To confi rm that the mRNA expression measured us-
ing microarrays was correct, we treated mouse bone 
50 ng/ml 25-hydroxycholesterol for 18 h. Cells were also treated 
with 25 or 50 ng/ml 25-hydroxycholesterol 30 min prior to stimu-
lation with LPS for 18 h. Culture media were collected and stored 
at   80°C for cytokine analysis. The amount of released Che-
mokine (C-C motif) ligand 5 (CCL5; RANTES) was determined 
by ELISA according to the manufacturer’s instructions (RnD 
Systems). 
 LPS injection in healthy subjects: study protocol 
 Healthy male volunteers (n = 8), age 26 ± 3 years, weight 74 ± 
9 kg, length 182 ± 5 cm, and body mass index 22 ± 2 kg/m 2 (mean ± 
SD) participated in the study ( 20) . All subjects were metaboli-
cally and otherwise healthy, as determined by medical history, 
physical examination, analyses of cell blood count, and biochem-
ical profi le. The study started in the morning at 8 AM after an 
overnight fast, and lasted for 8 h. At 4 h, all subjects received an 
intravenous injection of US Standard Reference  E. coli endotoxin 
at 4 ng/kg (Lot EC-6; US Pharmacopeia). Venous blood samples 
were collected in evacuated tubes containing EDTA, before and 
2 and 4 h after endotoxin administration. Informed consent was 
obtained from all subjects to participate in this study, which was 
approved by the local ethics committee of Karolinska Institutet at 
Huddinge University Hospital, Huddinge, Sweden. 
 The endotoxin model 
 Healthy volunteers were exposed to an endotoxin challenge. 
In small doses (4 ng/kg of body weight), endotoxin can safely be 
given to healthy individuals. It has been extensively used as a stan-
dardized human model for the early phase of sepsis ( 21, 22 ). En-
dotoxin initiates the immune response. This response is clinically 
manifested as the systemic infl ammatory response syndrome of 
septic shock caused by Gram-negative bacteria. It should be rec-
ognized that administration of small doses of endotoxin is not a 
model of septic shock. Yet, endotoxin challenge elicits typical re-
sponses seen in sepsis, such as in hemodynamics, pulmonary 
function, metabolism, as well as in the coagulation/fi brinolytic 
function and in effects upon infl ammatory cells, although not as 
pronounced. The cytokine response shows a typical pattern with 
an early rise of the pro-infl ammatory mediators tumor necrosis 
factor-  , followed by interleukin-1 (IL-1), IL-6, and IL-8 similar to 
what is seen in sepsis ( 21, 22 ). From a metabolical point of view, 
endotoxin challenge elicits pronounced changes in amino acid 
metabolism after 3 h with decreases of both plasma glutamate 
and glutamine by 25% ( 23 ). 
 RESULTS 
 Expression of cholesterol 25-hydroxylase mRNA is 
increased by LPS treatment 
 While studying the expression profi le induced by LPS 
and live  E. coli in mouse bone marrow-derived macrophages 
( 18 ), we noted that the expression of several genes in-
volved in cholesterol and oxysterol metabolism were not 
changed considerably by LPS treatment with the excep-
tion of the cholesterol 25-hydroxlyase gene  Ch25h ( Fig. 
1A ).  Ch25h mRNA expression was increased 35-fold ( P  = 
  0.002) in macrophages treated with 10 ng/ml repurifi ed 
LPS for 2 h compared with medium-treated controls. The 
increased  Ch25h mRNA expression was found to be tran-
sient with maximum expression reached at about 4 h after 
addition of LPS, and at 12 h, the expression had returned 
to a similar level of expression as before the LPS treatment 
 Fig.  1. The cholesterol 25-hydroxylase gene is induced by LPS. 
Bone marrow-derived macrophages were differentiated in vitro 
with GM-CSF for 8 d and then treated with 10 ng/ml repurifi ed 
 E.coli LPS or media only for 2 h (A). Total RNA was harvested, puri-
fi ed, and labeled, and gene expression analyzed by microarrays 
(Operon) with oligonucleotide reporters representing approxi-
mately 13,000 genes. Cells from four individual mice were used and 
analyzed in duplicate (n = 8 microarrays total). In B, macrophages 
were treated with repurifi ed  E. coli LPS, live  E. coli (one bacterium 
per macrophage), or media only for 0, 0.5, 1, 2, 4, 6, 12, and 24 h 
as indicated. Each line represents macrophages taken from one 
individual mouse. In C, macrophages were derived from  Tlr4   /   , 
 Myd88   /   , or C57Bl/6 control mouse bone marrow and treated 
with 10 ng/ml repurifi ed  E. coli LPS or media only for 2 h. Cells 
from four individual mice were used and analyzed in duplicate 
(n = 8 microarrays total). Fold changes represent expression com-
pared with media controls, i.e., a fold change of 1 indicates no 
change from media only treated cells. Average data ± SD are pre-
sented. Statistics were calculated with a Mann-Whitney test. 
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infl ammation. In  Fig. 4B ,  pretreatment of RAW264.7 mac-
rophages with 25 or 50 ng/ml 25-hydroxycholesterol for 
30 min, prior to LPS treatment for 18 h, did not alter the 
amount of CCL5 released into the medium. RAW264.7 
macrophages treated with increasing concentrations of 25-
hydroxycholesterol responded by producing CCL5 in a 
dose-dependent manner, confi rming that the small but 
signifi cant induction of CCL5 release was dependent on 
25-hydroxycholesterol. 
 25-hydroxycholesterol increases in the plasma of healthy 
volunteers after LPS challenge 
 To test if 25-hydroxycholesterol levels are increased 
during human endotoxaemia and sepsis, we adminis-
tered 4 ng/kg of US Standard Reference  E. coli LPS by 
intravenous injection to eight healthy volunteers and 
measured plasma oxysterols in sampled blood over time. 
Blood plasma levels of 25-hydroxycholesterol were sig-
nifi cantly increased over baseline levels 4 h after endo-
toxin challenge ( Fig. 5 ).  These results indicate that 
25-hydroxycholesterol may play a role in human endo-
toxaemia and sepsis. 
 DISCUSSION 
 Very little is known about the regulation of cholesterol 
25-hydroxylase. In an animal model where the gene re-
sponsible for the metabolism of 25-hydroxycholesterol, 
Cyp7b1, was disrupted, high circulatory levels of 25-
hydroxycholesterol and 27-hydroxycholesterol were observed 
( 25 ). These animals, lacking oxysterol 7  -hydroxylase, ap-
peared to have a normal overall cholesterol metabolism, 
and no alterations in infl ammatory parameters were re-
ported. Triple knockout mice defi cient in cholesterol 
24-hydroxylase, cholesterol 25-hydroxylase, and sterol 
27-hydroxylase have been generated and used in studies 
on LXR signaling. The gene disruptions resulted in re-
duced endogenous levels of 24-, 25-, and 27-hydroxycho-
lesterol to below levels of detection. However, phenotypic 
data on these mice were not reported (1 5 ). It has been 
reported previously that 25-hydroxy vitamin D 3 and 1,25-
dihydroxy vitamin D 3 can upregulate cholesterol 25-
hydroxylase in human primary prostate stromal cells 
( 26 ). In this work, we show that LPS induces cholesterol 
25-hydroxylase mRNA expression, which is accompanied 
by increased 25-hydroxycholesterol release from mouse 
macrophages. 
marrow-derived macrophages with either PBS or 10 ng/
ml repurifi ed  E. coli LPS for 2 h and analyzed the mRNA 
expression by quantitative real-time PCR.  Ch25h mRNA 
was found to be increased in LPS-treated macrophages 
by 51-fold over PBS-treated control macrophages, 
whereas  Cyp27a1 and  Cyp7b1 mRNA was not changed 
compared with control macrophages ( Fig. 2 A–C ).  The 
LPS-induced upregulation of  Ch25h mRNA expression 
presented a possibility that 25-hydroxycholesterol may 
have a function in infl ammation separate from other 
oxysterols. 
 25-hydroxycholesterol production and release from 
mouse macrophages is increased upon LPS treatment 
 To study if LPS treatment of macrophages also induces 
the production and release of 25-hydroxycholesterol, we 
treated mouse bone marrow-derived macrophages with 10 
ng/ml LPS for 6 or 24 h. The medium from untreated and 
LPS-treated cells was saved, and the adherent macrophages 
were thoroughly washed with PBS before they were 
scraped. Cellular oxysterols and oxysterols released into 
culture medium were extracted and analyzed by GC-MS 
and normalized to total cellular protein. LPS treatment 
increased macrophage 25-hydroycholesterol by 6- to 7-fold 
compared with untreated cells ( Fig. 3B )  and increased 25-
hydroxycholesterol released into the culture medium by 
1.5-fold at 6 h and by 2.2-fold at 24 h. 
 25-hydroxycholesterol induces release of 
pro-infl ammatory CCL5 cytokine but does not 
inhibit LPS-induced CCL5 release 
 To investigate if 25-hydroxycholesterol may have a func-
tion in promoting infl ammation, we treated RAW264.7 
mouse macrophages with 25 or 50 ng/ml 25-hydroxycho-
lesterol for 18 h and then measured CCL5 released into 
the medium normalized to total cellular protein. This is 
the same oxysterol concentrations found to be released 
from macrophages upon LPS treatment ( Fig. 3A ). Admin-
istration of CCL5 has previously been shown to increase 
sepsis-induced lethality in a cecal ligation and puncture 
model of septic peritonitis in mice, whereas CCL5 neutral-
ization improved survival ( 24 ). The 25-hydroxycholesterol 
treatment induced a small but signifi cant increase in CCL5 
released into the medium compared with control mac-
rophages. Next, to study if 25-hydroxycholesterol might 
have a role in limiting infl ammation, we reasoned that 
pretreatment of macrophages with 25-hydroxycholesterol 
might impair LPS-induced release of CCL5, thus limiting 
 Fig.  2. The cholesterol 25-hydroxylase gene, but not 
 Cyp27a1 or  Cyp7b1 , was induced by LPS. Bone marrow-
derived macrophages were differentiated in vitro with 
GM-CSF for 6 d and then treated with PBS (vehicle) or 
10 ng/ml  E. coli LPS for 2 h. Total RNA was isolated, and 
mRNA expression of  Ch25h  (A),  Cyp27a1  (B), and 
 Cyp7b1  (C) was analyzed by real-time PCR. Expression 
was normalized to   -actin expression and presented as 
expression relative to PBS-treated control cells. Average 
data ± SD are presented. Statistics were calculated with 
a Mann-Whitney test (n = 4 individual cultures). 
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 It has been reported previously that LPS treatment 
markedly decreased the activity and mRNA levels of CYP27 
in livers from Syrian hamsters and mice ( 34 ). In this study, 
no such decrease was observed in the mouse macrophages 
after 2 h ( Fig. 2 ). Furthermore, LPS treatment of healthy 
volunteers did not alter plasma levels of 27-hydroxycholes-
terol during the time window studied (data not shown). 
 It has been shown previously that 25-hydroxycholesterol 
stimulates the release of pro-infl ammatory cytokines in sev-
eral cellular systems. Treatment of human monocytes or 
THP-1 cells with 25-hydroxycholesterol stimulated the re-
lease of IL-8 ( 27, 28 ). Enhanced pro-infl ammatory cytokine 
secretion was also observed in U937 cells after 25-hydroxy-
cholesterol challenge ( 29, 30 ). This oxysterol also caused a 
dose-dependent increase in IL-1  secretion from human 
monocyte-derived macrophages and in addition stimulated 
IL-1  secretion induced by LPS ( 28 ). 25-Hydroxycholes-
terol treatment resulted in an enhanced production of 
both IL-1  and IL-8 in Caco-2 cells ( 31 ) and was also shown 
to be a potent inducer of infl ammation in retinal pigment 
epithelial cells ( 32 ). In macrophages, the pro-infl amma-
tory cytokine CCL5 has been shown to have a critical role 
for cell survival ( 33 ); consequently, we studied the effect of 
25-hydroxycholesterol on the release of CCL5 from mouse 
macrophages. Although a dose-dependent release of CCL5 
was observed, the amount released was so low compared 
with LPS-induced CCL5 release that it can be questioned if 
it has any biological meaning. On the other hand, it may 
be that tissue macrophages have a higher production of 
cytokines compared with isolated cells. Liu, Hulten, and 
Wiklund ( 27 ) showed that tissue macrophages produced 7 
times more IL-8 than monocytes and 100 times more than 
monocyte-derived macrophages. 
 Fig.  3. LPS-treated macrophages produce and release 25-
hydroxycholesterol. Bone marrow-derived macrophages were dif-
ferentiated in vitro with GM-CSF for 6 d and then treated with PBS 
(vehicle) or 10 ng/ml  E. coli LPS for 6 or 24 h. Medium (A) and 
cells (B) were collected and analyzed for 25-hydroxycholesterol 
content and normalized to total cellular protein. Average data ± SD 
are presented. **  P < 0.01 in a one-way ANOVA with Dunnett’s 
multiple testing correction compared with untreated cells (n = 4 
individual cultures). 
 Fig.  4. 25-Hydroxycholesterol treatment of macrophages in-
duced CCL5 expression. Mouse macrophage-like cells were treated 
under various conditions and the CCL5 released into the culture 
media was measured by ELISA. A: The mouse macrophage-like cell 
line RAW264.7 (in DMEM with 10% FCS) was treated with 25-
hydroxycholesterol for 18 h. B: RAW264.7 cells (in DMEM with 
10% FCS) were pretreated with 25-hydroxycholesterol for 30 min 
before treatment with 10 ng/ml LPS for 18 h. C: RAW264.7 
cells (in DMEM with 2% FCS) were treated with varying concen-
trations of 25-hydroxycholesterol for 18 h. Average data ± SD are 
presented. **  P < 0.01 in a one-way ANOVA with Dunnett’s mul-
tiple testing correction compared with untreated cells (n = 4 
individual cultures). Culture medium contained <1 ng/ml 
25-hydroxycholesterol. 
 at Univ of M
assachusetts M
edical School Library, on M
arch 6, 2020
w
w
w
.jlr.org
D
ow
nloaded from
 
LPS regulates cholesterol 25-hydroxylase expression 2263
  2 .  van Lier ,  J. E. , and  L. L.  Smith .  1967 .  Sterol metabolism. I. 26-
Hydroxycholesterol in the human aorta.  Biochemistry .  6 :  3269 – 3278 . 
  3 .  Björkhem ,  I. , and  J.  Gustafsson .  1974 .  Mitochondrial   -hydroxylation 
of cholesterol side chain.  J. Biol. Chem.  249 :  2528 – 2535 . 
  4 .  Lund ,  E. ,  I.  Björkhem ,  C.  Furster , and  K.  Wikvall .  1993 .  24-, 25- and 
27-hydroxylation of cholesterol by a purifi ed preparation of 27-
hydroxylase from pig liver.  Biochim. Biophys. Acta .  1166 :  177 – 182 . 
  5 .  Li ,  X. ,  W. M.  Pandak ,  S. K.  Erickson ,  Y.  Ma ,  L.  Yin ,  P.  Hylemon , and 
 S.  Ren .  2007 .  Biosynthesis of the regulatory oxysterol, 5-cholesten-
3beta,25-diol 3-sulfate, in hepatocytes.  J. Lipid Res.  48 :  2587 – 2596 . 
  6 .  Lund ,  E. G. ,  T. A.  Kerr ,  J.  Sakai ,  W-P.  Li , and  D. W.  Russell .  1998 . 
 cDNA cloning of mouse and human cholesterol 25-hydroxylases, 
polytopic membrane proteins that synthesize a potent oxysterol 
regulator of lipid metabolism.  J. Biol. Chem.  273 :  34316 – 34327 . 
  7 .  Dzeletovic ,  S. ,  O.  Breuer ,  E.  Lund , and  U.  Diczfalusy .  1995 . 
 Determination of cholesterol oxidation products in human plasma 
by isotope dilution-mass spectrometry.  Anal. Biochem.  225 :  73 – 80 . 
  8 .  Russell ,  D. W.  2000 .  Oxysterol biosynthetic enzymes.  Biochim. 
Biophys. Acta .  1529 :  126 – 135 . 
  9 .  Lehto ,  M. , and  V. M.  Olkkonen .  2003 .  The OSBP-related proteins: 
a novel protein family involved in vesicle transport, cellular lipid 
metabolism, and cell signalling.  Biochim. Biophys. Acta .  1631 :  1 – 11 . 
 10 .  Lagace ,  T. A. ,  D. M.  Byers ,  H. W.  Cook , and  N. D.  Ridgway .  1997 . 
 Altered regulation of cholesterol and cholesteryl ester synthesis in 
Chinese-hamster ovary cells overexpressing the oxysterol-binding 
protein is dependent on the pleckstrin homology domain.  Biochem. 
J.  326 :  205 – 213 . 
 11 .  Radhakrishnan ,  A. ,  Y.  Ikeda ,  H. J.  Kwon ,  M. S.  Brown , and  J. L. 
 Goldstein .  2007 .  Sterol-regulated transport of SREBPs from endo-
plasmic reticulum to Golgi: oxysterols block transport by binding 
to Insig.  Proc. Natl. Acad. Sci. USA .  104 :  6511 – 6518 . 
 12 .  Janowski ,  B. A. ,  P. J.  Willy ,  T. R.  Devi ,  J. R.  Falck , and  D. J. 
 Mangelsdorf .  1996 .  An oxysterol signalling pathway mediated by 
the nuclear receptor LXR  .  Nature .  383 :  728 – 731 . 
 13 .  Forman ,  B. M. ,  B.  Ruan ,  J.  Chen ,  G. J.  Schroepfer ,  Jr ., and  R. M. 
 Evans .  1997 .  The orphan nuclear receptor LXR  is positively and 
negatively regulated by distinct products of mevalonate metabo-
lism.  Proc. Natl. Acad. Sci. USA .  94 :  10588 – 10593 . 
 14 .  Björkhem ,  I.  2002 .  Do oxysterols control cholesterol homeostasis? 
 J. Clin. Invest.  110 :  725 – 730 . 
 15 .  Chen ,  W. ,  G.  Chen ,  D. L.  Head ,  D. J.  Mangelsdorf , and  D. W. 
 Russell .  2007 .  Enzymatic reduction of oxysterols impairs LXR sig-
naling in cultured cells and the livers of mice.  Cell Metab.  5 :  73 – 79 . 
 16 .  Infante ,  R. E. ,  L.  Abi-Mosleh ,  A.  Radhakrishnan ,  J. D.  Dale ,  M. S. 
 Brown , and  J. L.  Goldstein .  2008 .  Purifi ed NPC1 protein. I. Binding 
of cholesterol and oxysterols to a 1278-amino acid membrane pro-
tein.  J. Biol. Chem.  283 :  1052 – 1063 . 
 17 .  O’Neill ,  L. A. , and  A. G.  Bowie .  2007 .  The family of fi ve: TIR-
domain-containing adaptors in Toll-like receptor signalling.  Nat. 
Rev. Immunol.  7 :  353 – 364 . 
 18 .  Bjorkbacka ,  H. ,  K. A.  Fitzgerald ,  F.  Huet ,  X.  Li ,  J. A.  Gregory , 
 M. A.  Lee ,  C. M.  Ordija ,  N. E.  Dowley ,  D. T.  Golenbock , and  M. W. 
 Freeman .  2004 .  The induction of macrophage gene expression by 
LPS predominantly utilizes Myd88-independent signaling cascades. 
 Physiol. Genomics .  19 :  319 – 330 . 
 19 .  Folch ,  J. ,  M.  Lees , and  G. H.  Sloane Stanley .  1957 .  A simple method 
for the isolation and purifi cation of total lipids from animal tissues. 
 J. Biol. Chem.  226 :  497 – 509 . 
 20 .  Fredriksson ,  K. ,  U.  Fläring ,  C.  Guillet ,  J.  Wernerman , and  O. 
 Rooyackers .  2009 .  Muscle mitochondrial activity increases rapidly 
after an endotoxin challenge in human volunteers.  Acta Anaesthesiol. 
Scand.  53 :  299 – 304 . 
 21 .  Martich ,  G. D. ,  A. J.  Boujoukos , and  A. F. Suffredini .  1993 .  Response 
of Man to Endotoxin.  Immunobiology .  187 :  403 – 416 . 
 22 .  Lin ,  E. , and  S.  Lowry .  1998 .  The human response to endotoxin. 
 Sepsis .  2 :  255 – 262 . 
 23 .  Vesali ,  R. F. ,  M.  Klaude ,  O.  Rooyackers , and  J.  Wernerman .  2005 . 
 Amino acid metabolism in leg muscle after an endotoxin injec-
tion in healthy volunteers.  Am. J. Physiol. Endocrinol. Metab.  288 : 
 E360 – E364 . 
 24 .  Ness ,  T. L. ,  K. J.  Carpenter ,  J. L.  Ewing ,  C. J.  Gerard ,  C. M. 
 Hogaboam , and  S. L.  Kunkel .  2004 .  CCR1 and CC chemokine li-
gand 5 interactions exacerbate innate immune responses during 
sepsis.  J. Immunol.  173 :  6938 – 6948 . 
 25 .  Li-Hawkins ,  J. ,  E. G.  Lund ,  S. D.  Turley , and  D. W.  Russell .  2000 . 
 Disruption of the oxysterol 7alpha-hydroxylase gene in mice.  J. Biol. 
Chem.  275 :  16536 – 16542 . 
 Many in vitro cell culture studies have been conducted 
with 25-hydroxycholesterol, and a wide array of biological 
functions for 25-hydroxycholesterol have been suggested 
( 8 ). In addition to activation of LXR and regulation of 
lipid metabolism ( 12, 13 ), 25-hydroxycholesterol has been 
attributed both pro- and anti-infl ammatory functions ( 35, 
36 ), as well as a role in the induction of programmed cell 
death ( 37–39 ). Interestingly, transcriptional profi ling in 
macrophages has revealed that infl ammatory signaling in-
duced by LPS via TLR4 can regulate expression of LXR-
dependent lipid metabolism genes, whereas LXR activation 
in turn negatively regulates expression of infl ammatory 
genes ( 40, 41 ). Thus, LXR activation results in inhibition 
of macrophage gene expression of infl ammatory genes, 
such as iNOS, COX-2, IL-6, IL-1  , and G-CSF ( 30 ). In ad-
dition, LXR agonists show anti-infl ammatory activity on 
both acute and chronic infl ammation in murine in vivo 
models ( 30 ). Furthermore, the crosstalk between LXRs 
and TLRs has been found to be mediated by the TRIF-
dependent activation of IRF-3 ( 42 ). Taken together, these 
reports and our fi ndings raises the possibility that 25-
hydroxycholesterol may have a role in the crosstalk between 
infl ammatory signaling and lipid metabolism. 
 The potential role of 25-hydroxycholesterol in the cross-
talk between infl ammatory signaling and lipid metabolism 
may have consequences for atherosclerosis, a disease of the 
arteries driven by infl ammation and lipid accumulation. 
Increased production of 25-hydroxycholesterol by mac-
rophages, the prototypic cells of the atherosclerotic lesion, 
during infl ammation could lead to LXR activation, which 
has been shown to increase cholesterol effl ux and reverse 
cholesterol transport from lipid loaded macrophages. 
 In conclusion, we show here that 25-hydroxycholesterol, 
shown to act as an effi cient LXR ligand in vitro, is mark-
edly induced by LPS in mouse macrophages. Interestingly, 
LPS challenge in humans also increased plasma 25-
hydroxycholesterol levels.  
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